BioAge Labs Statistics
NASDAQ: BIOAHealthcareDrug Manufacturers - Specialty & GenericUSD
6.26-0.03 (-0.48%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BioAge Labs by the numbers
BioAge Labs has a market capitalization of $287.3 million based on 45.90M shares outstanding. With trailing EPS of $-2.39, BioAge Labs is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.1% below its 50-day average and 62.4% below its 200-day average.
Average daily trading volume is 915.59K shares, or about $5.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BIOA valuation vs. peer median
| Metric | BIOA | Peer median | Difference |
|---|---|---|---|
| Market cap | $287.31M | $252.74M | +14% |
| Avg. volume | 915.59K | 1.25M | -27% |
Peer median across 8 companies: ACB, ANIK, LFCR, AKBA, SIGA, EBS, CGC, ADCT.
Valuation
- Market cap
- $287.31M
- EPS (TTM)
- $-2.39
- Shares outstanding
- 45.90M
Price and trading
- Previous close
- 6.29
- Open
- 6.23
- Day range
- 6.20 – 6.68
- 52-week range
- 5.04 – 25.96
- 52-week change
- +11.79%
- Beta
- —
- Volume
- 799.45K
- Average volume
- 915.59K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 287.31M
- Forward Pe
- -2.59
- Eps
- -2.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.96
- Week52 Low
- 5.04
- Avg Volume
- 915.59K
- Shares Outstanding
- 45.90M
- Ma50
- 9.95
- Ma200
- 16.64
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -75.88%
- Pct From52w Low
- 24.21%